Illumina Body Map 2 (GSE30611)
Name | miRBASE accession |
---|---|
hsa-miR-205-5p
|
MIMAT0000266 |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_+_168291599 Show fit | 2.61 |
ENST00000265293.9
|
WW and C2 domain containing 1 |
|
chr16_+_86510507 Show fit | 2.56 |
ENST00000262426.6
|
forkhead box F1 |
|
chr2_-_187448244 Show fit | 1.63 |
ENST00000392370.8
ENST00000410068.5 ENST00000447403.5 ENST00000410102.5 |
calcitonin receptor like receptor |
|
chr11_-_115504389 Show fit | 1.31 |
ENST00000545380.5
ENST00000452722.7 ENST00000331581.11 ENST00000537058.5 ENST00000536727.5 ENST00000542447.6 |
cell adhesion molecule 1 |
|
chr3_-_64687613 Show fit | 1.30 |
ENST00000295903.8
|
ADAM metallopeptidase with thrombospondin type 1 motif 9 |
|
chr12_+_56080155 Show fit | 1.20 |
ENST00000267101.8
|
erb-b2 receptor tyrosine kinase 3 |
|
chr16_+_4371840 Show fit | 1.01 |
ENST00000304735.4
|
vasorin |
|
chr16_+_50548387 Show fit | 0.87 |
ENST00000268459.6
|
NKD inhibitor of WNT signaling pathway 1 |
|
chr4_+_76435216 Show fit | 0.82 |
ENST00000296043.7
|
shroom family member 3 |
|
chr10_+_58512864 Show fit | 0.82 |
ENST00000373886.8
|
BicC family RNA binding protein 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.9 | 2.6 | GO:0060458 | right lung development(GO:0060458) |
0.1 | 1.6 | GO:0009744 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 1.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.1 | 1.3 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.0 | 1.2 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.2 | 1.0 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.3 | 0.9 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.8 | GO:0045176 | apical protein localization(GO:0045176) |
0.1 | 0.7 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 0.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.6 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.5 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.5 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.4 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.1 | 0.3 | GO:0005606 | laminin-1 complex(GO:0005606) laminin-10 complex(GO:0043259) laminin-11 complex(GO:0043260) |
0.1 | 0.3 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) TEAD-2-YAP complex(GO:0071149) |
0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 2.4 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 2.0 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.4 | 1.6 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 1.2 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 1.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 0.7 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.0 | 0.7 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.6 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 1.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.0 | 0.3 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.6 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 1.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.6 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
0.0 | 0.6 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.5 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.0 | 0.3 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |